ELTX — Elicio Therapeutics, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1601485 ·
Last close
$1.43
Market Cap
$40.48M
52W High
$16.00
52W Low
$1.25
ADV30
309,150
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -8,452,000 -7,979,000 39,596,000 30,900,000 20,745,000
Jun 2026 0 — -10,429,000 -8,217,000 31,330,000 23,480,000 23,393,000
Mar 2026 0 — -10,602,000 -11,823,000 22,689,000 14,948,000 24,126,000
Dec 2025 0 — -8,842,000 -7,718,000 25,862,000 18,563,000 24,226,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-37,693,000
Investing CF
$-16,000
Financing CF
$38,972,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.34
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-253,712,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-36,261,000
Pretax Income TTM
$-37,841,000
Interest Exp TTM
$1,580,000
Analysts
3

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -37,299,000 -39,571,000 25,862,000 24,226,000 1,636,000 -36,952,000
Dec 2024 0 -44,986,000 -51,898,000 28,178,000 39,490,000 -11,312,000 -37,068,000
Dec 2023 0 -35,745,000 -35,195,000 27,146,000 15,773,000 11,373,000 -32,694,000
Dec 2022 0 -23,733,000 -28,208,000 22,664,000 124,809,000 -102,145,000 -22,179,000

TTM Snapshot

Revenues TTM
$29,436,000
NetIncome TTM
$-37,841,000
OpCashFlow TTM
—
Assets (Latest)
$31,330,000
Forward EPS
$-1.69

Max Pain — expiry 2027-05-21 (volume-derived — Yahoo OI feed degraded)

max pain strike: $2.50 · spot: $1.59 · call volume: 361 · put volume: 0
Expected Move to 2027-05-21: ±$1.52 (95.60%) — implied range $0.07 – $3.11 · ATM straddle on $2.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
PLRX PLIANT THERAPEUTICS, INC. $40.93M $0.66 —
DWTX Dogwood Therapeutics, Inc. $41.29M $1.08 —
TLPH TALPHERA, INC. $41.61M $0.80 —
ALDX Aldeyra Therapeutics, Inc. $41.88M $0.69 —
ATNM Actinium Pharmaceuticals, Inc. $42.45M $1.35 —

News headlines (Yahoo Finance, 1h cache)

Elicio Therapeutics: Q3 Earnings Snapshot
2026-11-05 21:15 · Yahoo
Elicio Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-05 21:01 · Yahoo
Elicio Therapeutics to Host Virtual KOL Event on November 11, 2026: ELI-002 7P for Metastatic and Neoadjuvant PDAC
2026-11-04 13:00 · Yahoo
Elicio Therapeutics to Present Phase 2 AMPLIFY-7P Results at the SITC 2026 Annual Meeting
2026-10-29 13:00 · Yahoo
Elicio Therapeutics Presents Late-Breaking Phase 2 AMPLIFY-7P Results at ESMO Congress 2026 and Announces Simultaneous Publication in Nature Medicine
2026-10-23 13:00 · Yahoo
Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026
2026-09-24 12:00 · Yahoo
Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference
2026-08-31 12:00 · Yahoo
Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
2026-08-24 12:00 · Yahoo
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering
2026-07-02 04:25 · Yahoo
Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes
2026-06-29 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.